Oxford BioDynamics (OBD.L): EpiSwitch™ platform selected in COVID-19 biomarker study
30 Apr 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Oxford BioDynamics PLC (OBD:LON) | 8.9 0 0.0% | Mkt Cap: 27.7m
- Published:
30 Apr 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Oxford BioDynamics (OBD.L): EpiSwitch™ platform selected in COVID-19 biomarker study